Skip to main content

Market Overview

11 Healthcare Stocks Moving In Tuesday's Pre-Market Session

Share:

Gainers

  • Neovasc, Inc. (NASDAQ: NVCN) shares moved upwards by 168.3% to $10.60 during Tuesday's pre-market session. The most recent rating by H.C. Wainwright, on October 24, is at Buy, with a price target of $9.00.
  • Savara, Inc. (NASDAQ: SVRA) shares increased by 10.6% to $5.43.
  • Onconova Therapeutics, Inc. (NASDAQ: ONTX) shares moved upwards by 6.4% to $0.51.
  • Innate Pharma, Inc. (NASDAQ: IPHA) shares increased by 5.6% to $6.79.
  • Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) shares rose 2.3% to $0.22. The most recent rating by Maxim Group, on October 23, is at Buy, with a price target of $1.00.
  • Sierra Oncology, Inc. (NASDAQ: SRRA) shares moved upwards by 1.3% to $0.34. The most recent rating by Oppenheimer, on December 06, is at Outperform, with a price target of $1.20.

 

Losers

  • Cassava Sciences, Inc. (NASDAQ: SAVA) shares declined 6.5% to $5.72 during Tuesday's pre-market session.
  • Rite Aid, Inc. (NYSE: RAD) stock plummeted 4.1% to $15.29.
  • Genocea Biosciences, Inc. (NASDAQ: GNCA) shares decreased by 3.8% to $2.03. According to the most recent rating by SVB Leerink, on November 15, the current rating is at Outperform.
  • Ocugen, Inc. (NASDAQ: OCGN) stock fell 1.6% to $0.57. According to the most recent rating by H.C. Wainwright, on December 20, the current rating is at Buy.
  • Melinta Therapeutics, Inc. (NASDAQ: MLNT) stock decreased by 1.1% to $0.46.
 

Related Articles (GNCA + IPHA)

View Comments and Join the Discussion!

Posted-In: Healthcare Stocks Pre-Market MoversNews Movers & Shakers Pre-Market Outlook Markets Movers Trading Ideas General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com